oxidopamine has been researched along with Chronic Pain in 4 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic pain is a common and undertreated nonmotor symptom in Parkinson's disease (PD)." | 1.62 | D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice. ( Luan, YW; Tang, DL; Xiao, C; Zhou, CY, 2021) |
| "Chronic pain is the most common non-motor symptom among Parkinson's disease (PD) patients, with 1." | 1.51 | Effects of subthalamic deep brain stimulation with gabapentin and morphine on mechanical and thermal thresholds in 6-hydroxydopamine lesioned rats. ( Feustel, P; Kaszuba, BC; Maietta, T; Pilitsis, JG; Shin, DS; Slyer, J; Stapleton, A; Walling, I, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahbaie, P | 1 |
| Li, WW | 1 |
| Guo, TZ | 1 |
| Shi, XY | 1 |
| Kingery, WS | 1 |
| Clark, JD | 1 |
| Tang, DL | 1 |
| Luan, YW | 1 |
| Zhou, CY | 1 |
| Xiao, C | 1 |
| Vergara, F | 1 |
| Sardi, NF | 1 |
| Pescador, AC | 1 |
| Guaita, GO | 1 |
| Jark Stern, CA | 1 |
| Chichorro, JG | 1 |
| Fischer, L | 1 |
| Kaszuba, BC | 1 |
| Maietta, T | 1 |
| Walling, I | 1 |
| Feustel, P | 1 |
| Stapleton, A | 1 |
| Shin, DS | 1 |
| Slyer, J | 1 |
| Pilitsis, JG | 1 |
4 other studies available for oxidopamine and Chronic Pain
| Article | Year |
|---|---|
Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.
Topics: Animals; Autonomic Nervous System; Chronic Pain; Complex Regional Pain Syndromes; Disease Models, An | 2022 |
D2 receptor activation relieves pain hypersensitivity by inhibiting superficial dorsal horn neurons in parkinsonian mice.
Topics: Action Potentials; Animals; Chronic Pain; Dopamine Agonists; Dopamine Antagonists; Indoles; Male; Mi | 2021 |
Contribution of mesolimbic dopamine and kappa opioid systems to the transition from acute to chronic pain.
Topics: Acute Pain; Analgesics, Opioid; Animals; Chronic Pain; Dinoprostone; Disease Progression; Dopamine; | 2020 |
Effects of subthalamic deep brain stimulation with gabapentin and morphine on mechanical and thermal thresholds in 6-hydroxydopamine lesioned rats.
Topics: Animals; Chronic Pain; Deep Brain Stimulation; Disease Models, Animal; Gabapentin; Male; Morphine; O | 2019 |